Two Indian Vaccines Completed Phase I Trials: ICMR Chief

Vaccine candidates by Bharat Biotech and Zydus Cadilla have completed Phase I trials of their indigenious vaccines, informed Balrama Bhargava, Director General of the Indian Council of Medical Research said in a press conference. 

Bharat Biotech's inactivated virus vaccine has completed trials at 11 sites while Zydus Cadilla's plasmid DNA vaccine has completed trials in 17 sites too. 

Serum Institute of India's Oxford vaccine will start Phase III trials.